Thursday, June 19, 2014
Aldehyde dehydrogenase (ALDH);
proto-oncogene (MET; HGFR); epidermal growth factor receptor 1
Cell culture and mouse
studies suggest ALDH inhibitors could help treat cancer. In human cancer cell
lines expressing MET or EGFR1, the acquisition of resistance to inhibitors
was associated with upregulation of ALDH. In multiple kinase-dependent cancer
cell lines, an ALDH inhibitor plus an inhibitor of the respective kinase
increased cell death compared with either agent alone. In mice bearing
EGFR1-dependent xenograft lung tumors, an ALDH inhibitor plus an EGFR1
inhibitor decreased tumor growth and increased time to tumor recurrence
compared with an EGFR1 inhibitor alone. Ongoing work includes testing ALDH
inhibitors in mouse models of other cancers.
Pharmaceuticals Corp. has TKM-ALDH2,
an siRNA targeting aldehyde
dehydrogenase 2 family mitochondrial (ALDH2)
formulated using lipid nanoparticle delivery technology, in preclinical
testing to treat addiction.
Published online June 19, 2014
Patent and licensing status
Raha, D. et al. Cancer
published online May 8, 2014;
Contact: Jeff Settleman, Genentech Inc.,
San Francisco, Calif.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]